Shop

Showing 1233–1248 of 1900 results

Article: P1.09 RASSF4 functions as a tumor suppressor in Multiple Myeloma
€2.42 Add to cart
Article: P1.10 Immunoglobulin and T-cell receptor gene analysis by next-generation sequencing
€2.42 Add to cart
Article: P1.10 Immunomodulatory effects of Rapamycin in xenogeneic GVHD
€2.42 Add to cart
Article: P1.10 Lactic acidosis as an atypical presentation of a diffuse large B-cell lymphoma
€2.42 Add to cart
Article: P1.11 Acute myeloblastic leukemia infiltrating-T lymphocyte characterization, from bone marrow and peripheral blood
€2.42 Add to cart
Article: P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype
€2.42 Add to cart
Article: P1.11 Retrospective Chart Review of Hospitalisations and Costs Associated with the Treatment of Adults with Philadelphia-negative (-) B-precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) in Belgium
€2.42 Add to cart
Article: P1.12 Chronic EBV infection resulting in a CD20 negative lymphoproliferative disorder complicated with secondary hemophagocytosis
€2.42 Add to cart
Article: P1.12 Identification of clinical and biological parameters predictive of chemotherapy completion and two-year overall survival in clinically fit older patients with haematological malignancies
€2.42 Add to cart
Article: P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool
€2.42 Add to cart
Article: P1.13 Blocking S100A9 interactions in the Multiple Myeloma bone marrow environment reduces angiogenesis and tumor growth
€2.42 Add to cart
Article: P1.13 Temsirolimus in daily clinical practice: results from the Belgian mantle cell lymphoma registry
€2.42 Add to cart
Article: P1.14 Molecular biology vs. Statistics: A patient with concomitantly occurring CLL and MPN
€2.42 Add to cart
Article: P1.14 Monoclonal B-cell lymphocytosis (MBL): results of a routine screening in a general hospital
€2.42 Add to cart
Article: P1.15 Multiple Myeloma in Black Africans, clinical and biological characteristics
€2.42 Add to cart
Article: P1.15 Outcome after salvage chemotherapy with DHAP/ICE-type regimens and attempt to transplant in patients with aggressive lymphoma: experience of a single centre
€2.42 Add to cart

Article: P1.09 RASSF4 functions as a tumor suppressor in Multiple Myeloma

Article: P1.10 Immunoglobulin and T-cell receptor gene analysis by next-generation sequencing

Article: P1.10 Immunomodulatory effects of Rapamycin in xenogeneic GVHD

Article: P1.10 Lactic acidosis as an atypical presentation of a diffuse large B-cell lymphoma

Article: P1.11 Acute myeloblastic leukemia infiltrating-T lymphocyte characterization, from bone marrow and peripheral blood

Article: P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype

Article: P1.11 Retrospective Chart Review of Hospitalisations and Costs Associated with the Treatment of Adults with Philadelphia-negative (-) B-precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) in Belgium

Article: P1.12 Chronic EBV infection resulting in a CD20 negative lymphoproliferative disorder complicated with secondary hemophagocytosis

Article: P1.12 Identification of clinical and biological parameters predictive of chemotherapy completion and two-year overall survival in clinically fit older patients with haematological malignancies

Article: P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool

Article: P1.13 Blocking S100A9 interactions in the Multiple Myeloma bone marrow environment reduces angiogenesis and tumor growth

Article: P1.13 Temsirolimus in daily clinical practice: results from the Belgian mantle cell lymphoma registry

Article: P1.14 Molecular biology vs. Statistics: A patient with concomitantly occurring CLL and MPN

Article: P1.14 Monoclonal B-cell lymphocytosis (MBL): results of a routine screening in a general hospital

Article: P1.15 Multiple Myeloma in Black Africans, clinical and biological characteristics

Article: P1.15 Outcome after salvage chemotherapy with DHAP/ICE-type regimens and attempt to transplant in patients with aggressive lymphoma: experience of a single centre